ESCMID 2025
Driving innovation across in-vitro diagnostics
CPI is attending ESCMID conference in Vienna in April, where our experts will be available to discuss our cutting-edge innovations across in-vitro diagnostics (IVD).
At CPI, we collaborate with industry partners to accelerate the development of their cutting-edge health technologies, helping to address global healthcare challenges and bring breakthrough solutions to market.
Let’s connect and explore how we can drive innovation together.
About CPI
CPI is a leading technology innovation catalyst with 20 years of experience in developing, proving, scaling-up, and commercialising disruptive and transformative innovations. Our expertise spans several HealthTech markets, including minimally-invasive devices, drug-device combinations, and biosensors/wearables.
-
500+ scientists and engineers.
-
€235m of innovation facilities and equipment.
-
We have delivered 1,500+ R&D&I projects, which has unlocked €4 billion private investment into R&D&I.
Our expertise
At CPI, we excel in:
-
Instruments: Developing precision technologies that require advanced engineering, scalable production, and compliance with strict regulations.
-
Assays and reagents: Ensuring consistent performance with scalable production, balancing sensitivity and specificity while meeting rigorous standards
-
Consumables: Designing user-friendly, reliable consumables that are critical for market adoption
Some examples of how CPI has helped businesses:
-
Process development and scale up of reagents for IVD: fermentation process development for scaled up production of glycopeptides, recombinant proteins and enzymes.
-
Printed biosensors for chronic disease: innovation in nano-ink formulation and development of controlled, scalable printing processes enabled the volume production of multiplexed electrochemical IVD devices with improved sensitivity, selectivity and reproducibility.
Why connect with us?
Discover how CPI works with companies of all sizes to accelerate their IVD development from technology and opportunity definition to development and scale-up. Our expert teams and advanced facilities ensure your devices, consumables, assays, and reagents are ready for clinical use, getting your product into clinical settings faster.
Our team
At ESCMID Cheryl Dean, Business Development Manager and Dr Craig Manning, Team Leader – IVD Technology, will be available for a coffee and chat.
Please feel free to reach out to them and book a meeting.
A strategic technology roadmap for the UK IVD industry
Highlighting opportunities that the UK IVD industry must address over the next 10 years and predicting the technology developments needed to realise them.Let’s innovate together
To find out more about how we can work together, please enter your details below.